Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia® (ferric citrate)
09 nov. 2016 10h41 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update
09 nov. 2016 07h01 HE
|
Keryx Biopharmaceuticals, Inc.
The company has established adequate supply of Auryxia® (ferric citrate) and is prepared to make this medicine available to people on dialysis pending U.S. FDA approval of second contract...
Keryx Biopharmaceuticals to Webcast its Presentation at Stifel’s 2016 Healthcare Conference on November 15
03 nov. 2016 08h31 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
01 nov. 2016 09h15 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal...
Keryx Biopharmaceuticals Announces Presentations of Data at the American Society of Nephrology Kidney Week 2016 Annual Meeting
14 oct. 2016 10h12 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference
21 sept. 2016 08h30 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences
01 sept. 2016 08h30 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results
01 août 2016 07h30 HE
|
Keryx Biopharmaceuticals, Inc.
- Supply interruption does not affect the safety profile of currently available Auryxia -- Company withdraws its 2016 financial guidance -- Company to host conference call today at 8:30 a.m. EDT - ...
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2016 Financial Results on Monday, August 1, 2016
29 juil. 2016 08h30 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, July 29, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy
27 juin 2016 08h00 HE
|
Keryx Biopharmaceuticals, Inc.
BOSTON, June 27, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...